Annual Drug Patent Expirations for RINVOQ+LQ Rinvoq Lq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. The generic ingredient in RINVOQ LQ is upadacitinib. One supplier is listed for this compound. Additional…
Annual Drug Patent Expirations for JAKAFI Jakafi is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge. Drug patent litigation for JA…
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA. It is available from three suppliers. There are twenty-nine patents protecting this drug and two Paragraph IV challenges. XIFAXAN drug pri…
New patent expiration for Salix Pharms drug XIFAXAN Read Post »
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in two NDAs. It is available from one supplier. There are thirty-three patents protecting this drug. Drug patent litigation for RINVOQ. This drug has one hund…
This chart shows the drugs with the most patents in New Zealand. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. The companies with the greatest patent coverage in New Zealand are: Tr…
Which pharmaceutical drugs have the most drug patents in New Zealand? Read Post »
Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point. Branded generics can be an a…
Maximizing ROI with Branded Generics: A Comprehensive Guide Read Post »
Annual Drug Patent Expirations for RISVAN Risvan is a drug marketed by Labs Farms Rovi Sa and is included in one NDA. The generic ingredient in RISVAN is risperidone. Additional details are available on the risperidone profile page. For more informatio…
Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. DUOBRII drug price trends. Drug patent litigation for DUOBRII. …
Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug. This drug has fifty-nine patent family members in twenty-…
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It is available from seven suppliers. There are two patents protecting this drug and two Paragraph IV challenges. NUVIGIL drug price trends. D…
Get new actionable insights and updates from BiotechBlog
